However, elevated CA125 is also observed in other diseases, i.e., pancreatic, lung, breast, colorectal and gastrointestinal cancer or some benign conditions, i.e., cirrhosis, hepatitis 6, which compromises the specificity of CA125 in ovarian cancer. This evidence concerns the gene MUC16 and ovarian carcinoma.